ACTIVE

Dr. D. VANWALLEGHEM

Export PDF

Financial year 2025 · closed on 31/03/2025

Net result

193,5 k €

+2.6% YoY

Gross margin

284,5 k €

-0.8% YoY

Equity

912,3 k €

+16.6% YoY

What does Dr. D. VANWALLEGHEM do?

Dr. D. VANWALLEGHEM is a Private limited company incorporated in 2005. Its main activity is: General medical practice activities. Its registered office is in Wetteren.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0871.241.825

Incorporation

17/01/2005

Legal form

Private limited company

Registered office

Wetterensteenweg 58
9230 Wetteren · FlandreSee on map

Contributed capital

18 600,00 €

Latest accounts

31/03/2025

Activities (NACE)

86210General medical practice activities· main 86210General medical practice activities 86909Other human health activities 86995Other human health activities

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 13 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013
Income statement
Gross margin	284,5 k €	-0.8%	286,7 k €	+43.5%	199,8 k €	-10.7%	223,7 k €	+3.5%	216,1 k €	+57.8%	137 k €	+38.6%	98,8 k €	+50.7%	65,6 k €	+82.7%	35,9 k €	+56.1%	23 k €	-20.8%	29 k €	-1.7%	29,5 k €	-34.0%	44,7 k €
EBITDA	283,7 k €	-1.0%	286,4 k €	+43.5%	199,6 k €	-10.7%	223,5 k €	+3.5%	216 k €	+58.0%	136,7 k €	+38.7%	98,6 k €	+50.9%	65,3 k €	+83.4%	35,6 k €	+56.7%	22,7 k €	-21.0%	28,8 k €	-1.9%	29,3 k €	-34.1%	44,5 k €
Operating result	267,9 k €	-1.0%	270,7 k €	+39.1%	194,6 k €	-9.1%	214,2 k €	+3.8%	206,3 k €	+62.6%	126,8 k €	+40.6%	90,2 k €	+57.4%	57,3 k €	+80.8%	31,7 k €	+84.8%	17,2 k €	+122%	7,7 k €	+162%	3 k €	-84.2%	18,7 k €
Net result	193,5 k €	+2.6%	188,7 k €	+38.7%	136 k €	-8.2%	148,1 k €	+3.3%	143,4 k €	+62.9%	88,1 k €	+39.1%	63,3 k €	+82.0%	34,8 k €	+82.2%	19,1 k €	+96.7%	9,7 k €	+145%	4 k €	+153%	1,6 k €	-88.3%	13,3 k €
Balance sheet
Equity	912,3 k €	+16.6%	782,2 k €	+24.5%	628,3 k €	+22.5%	513 k €	+36.4%	376,2 k €	+60.5%	234,4 k €	+58.4%	147,9 k €	+71.6%	86,2 k €	+67.6%	51,5 k €	+59.0%	32,4 k €	+42.8%	22,7 k €	+7.4%	21,1 k €	-3.8%	22 k €
Total assets	946,2 k €	+15.0%	822,6 k €	+22.0%	674,4 k €	+15.6%	583,4 k €	+36.6%	427,2 k €	+50.2%	284,4 k €	+56.9%	181,2 k €	+41.1%	128,4 k €	+16.7%	110 k €	+76.9%	62,2 k €	-8.7%	68,1 k €	-9.4%	75,2 k €	-30.0%	107,5 k €
Cash	672,8 k €	+53.8%	437,3 k €	-23.4%	571 k €	+4.8%	544,8 k €	+45.3%	375 k €	+52.4%	246,1 k €	+68.2%	146,3 k €	+50.6%	97,1 k €	+2.9%	94,4 k €	+88.2%	50,1 k €	-1.5%	50,9 k €	+13.2%	45 k €	-17.6%	54,6 k €
Debts	33,6 k €	-16.5%	40,2 k €	-12.7%	46,1 k €	-34.5%	70,4 k €	+38.0%	51 k €	+2.0%	50 k €	+50.4%	33,3 k €	-21.1%	42,2 k €	-9.4%	46,6 k €	+56.1%	29,8 k €	-25.4%	40 k €	-26.0%	54,1 k €	-35.4%	83,7 k €

Estimate

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/03/2025 · 1 active · 2 ended

Active mandates

Danny Vanwalleghem

Director · since 05 janvier 2005

Active

Ended mandates

Danny Vanwalleghem

Director

Ended

Danny Vanwalleghem

Manager

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Micro model	Micro model	Micro model	Micro model	Micro model	Micro model
Start of the financial year	01/04/2024	01/04/2023	01/04/2022	01/04/2021	01/04/2020	01/04/2019
Closing of the financial year	31/03/2025	31/03/2024	31/03/2023	31/03/2022	31/03/2021	31/03/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	13/10/2025	30/10/2024	26/10/2023	21/10/2022	30/09/2021	21/09/2020
General meeting	15/09/2025	27/08/2024	25/09/2023	23/09/2022	09/09/2021	25/08/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

19 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Micro model	31/03/2025	15/09/2025	13/10/2025	Dutch	PDF
Micro model	31/03/2024	27/08/2024	30/10/2024	Dutch	PDF
Micro model	31/03/2023	25/09/2023	26/10/2023	Dutch	PDF
Micro model	31/03/2022	23/09/2022	21/10/2022	Dutch	PDF
Micro model	31/03/2021	09/09/2021	30/09/2021	Dutch	PDF
Micro model	31/03/2020	25/08/2020	21/09/2020	Dutch	PDF
Micro model	31/03/2019	27/08/2019	20/09/2019	Dutch	PDF
Micro model	31/03/2018	28/08/2018	26/10/2018	Dutch	PDF
Abridged model	31/03/2017	29/08/2017	27/10/2017	Dutch	PDF
Abridged model	31/03/2016	30/08/2016	28/10/2016	Dutch	PDF
Abridged model	31/03/2015	25/08/2015	05/10/2015	Dutch	PDF
Abridged model	31/03/2014	26/08/2014	09/10/2014	Dutch	PDF
Abridged model	31/03/2013	27/08/2013	22/10/2013	Dutch	PDF
Abridged model	31/03/2012	28/08/2012	22/10/2012	Dutch	PDF
Abridged model	31/03/2011	30/08/2011	22/09/2011	Dutch	PDF
Abridged model	31/03/2010	31/08/2010	14/09/2010	Dutch	PDF
Abridged model	31/03/2009	25/08/2009	24/09/2009	Dutch	PDF
Abridged model	31/03/2008	26/08/2008	11/09/2008	Dutch	PDF
Abridged model	31/03/2007	28/08/2007	20/09/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/03/2025 · 1 active · 2 ended

Active mandates

Danny Vanwalleghem

Director · since 05 janvier 2005

Active

Ended mandates

Danny Vanwalleghem

Director

Ended

Danny Vanwalleghem

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates23/02/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DIVERSEN - DOEL - ONTSLAGEN - BENOEMINGEN
PDF
Mandates28/01/2016
ONTSLAGEN - BENOEMINGEN
PDF
Other25/01/2005
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 2025193,5 k €↑
2024
Annual accounts 2024188,7 k €↑
2023
Annual accounts 2023136 k €↓
2023
Name changeDR. D. VANWALLEGHEM
2022
Annual accounts 2022148,1 k €↑
2022
Name changeVanwalleghem D Dokter
2021
Annual accounts 2021143,4 k €↑
2020
Annual accounts 202088,1 k €↑
2019
Annual accounts 201963,3 k €↑
2018
Annual accounts 201834,8 k €↑
2017
Annual accounts 201719,1 k €↑
2016
Annual accounts 20169,7 k €↑
2015
Annual accounts 20154 k €↑
2014
Annual accounts 20141,6 k €↓
2013
Annual accounts 201313,3 k €
17/01/2005
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Dr. D. VANWALLEGHEM

Overview

What does Dr. D. VANWALLEGHEM do?

Trend over 13 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline